Kymera Investor Day Presentation Deck slide image

Kymera Investor Day Presentation Deck

Agenda IRAK4 Degrader KT-474 Ph1 HV study: SAD/MAD data IRAKIMID Degrader KT-413 Update and Clinical Plans • STAT3 Degrader KT-333 Update and Clinical Plans • STAT3 Degraders in Immune-inflammation and Fibrosis KYMERA ©2021 KYMERA THERAPEUTICS, INC. KYMERA R&D DAY - December 16th, 2021 PAGE 18
View entire presentation